InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,426.40
(
0.12%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.77
(
-0.02%
)
Bitcoin
65,157.23
(
0.03%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

glass_half_full

Send PM Follow Ignore
Followers 6
Posts 1203
Boards Moderated 0
Alias Born 12/09/2006

glass_half_full

Re: dogpal2 post# 9392

Thursday, 06/16/2011 7:52:09 AM

Thursday, June 16, 2011 7:52:09 AM

Post# of 80490
So as I read it, '113

1. Blocks EGFR as well as ALK,

2. Will be in a "Phase 1/2" trial (I assume that's phases 1 & 2 rather than phase 0.5), and

3. Won't start in the clinic until Q3 -- which is a bit of a delay IIRC, but the idea is that we will have a much more compelling trial.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up